| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO and COO | Chief Financial Officer | Chief Executive Officer
2 companies
Plavan Matthew T serves as a CFO and COO at ORGN and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 6 buys and 6 sells. Those positions are worth an estimated $306K at current prices.
Historically, Plavan Matthew T's trades have earned a strong insider score of 77/100 across 6 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +74.2%.
The biggest single holding is ORGN (~$261K) as CFO and COO. The recent filings there lean toward selling, a net 356,225 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | ORGN Origin Materials, Inc. | CFO and COO | Sell | 12,000 | $0.20 | $2,392.80 | -0.9% | +1027.0% | - | |
| Dec 26, 2025 | ORGN Origin Materials, Inc. | CFO and COO | Sell | 40,000 | $0.21 | $8,384.00 | -2.9% | +1646.5% | - | |
| Nov 3, 2025 | ORGN Origin Materials, Inc. | CFO and COO | Sell | 150,000 | $0.55 | $82,500.00 | -9.9% | -66.6% | - | |
| Mar 5, 2025 | ORGN Origin Materials, Inc. | CFO and COO | Sell | 9,725 | $0.86 | $8,343.08 | -0.6% | -48.6% | -82.8% | |
| Dec 27, 2024 | ORGN Origin Materials, Inc. | CFO and COO | Sell10b5-1 | 24,500 | $1.02 | $25,110.05 | -1.7% | -29.4% | -80.1% | |
| Nov 4, 2024 | ORGN Origin Materials, Inc. | Chief Financial Officer | Sell | 120,000 | $1.32 | $157,860.00 | -8.9% | -26.7% | -59.8% | |
| Aug 3, 2020 | RKDA Arcadia Biosciences, Inc. | Chief Executive Officer | Buy | 585 | $3.16 | $1,848.60 | +4.3% | - | - | |
| Feb 3, 2020 | RKDA Arcadia Biosciences, Inc. | Chief Executive Officer | Buy | 700 | $1.72 | $1,204.00 | +5.4% | - | - | |
| Nov 14, 2019 | RKDA Arcadia Biosciences, Inc. | Chief Executive Officer | Buy | 1,000 | $4.08 | $4,079.50 | +8.3% | - | - | |
| Sep 23, 2019 | RKDA Arcadia Biosciences, Inc. | Chief Executive Officer | Buy | 2,000 | $5.25 | $10,500.00 | +20.0% | - | - |